Skip to main content

$1.14 -0.01 (-0.44%)

High

$1.17

Low

$1.13

Trades

1,304

Turnover

$2,983,889

Volume

2,606,681
30 June 2023 at 4:10pm
Register to track MSB and receive email alerts.
These articles are automatically gathered and therefore may not always be accurate. It is also not possible to guarantee that discovery/publishment dates are accurate.
MSB Media Articles (3 months, all sources, average 0.00 per day)

Latest Media Articles

Site
Zip Co, Mesoblast among ASX's best performers in 2024

canberratimes.com.au, discovered 31-Dec at 4:01pm

Mesoblast After Approval: Stock Is Buoyant Now, But Unpredictable Over...

seekingalpha.com, discovered 31-Dec at 10:01am

Remestemcel-L by Mesoblast for Crohn’s Disease (Regional Enteritis): L...

pharmaceutical-technology.com, discovered 31-Dec at 4:27am

Mesoblast Sees Major Change in Substantial Holding

markets.businessinsider.com, discovered 27-Dec at 9:19am

Mesoblast (NASDAQ:MESO) Cut to Hold at Jefferies Financial Group

etfdailynews.com, discovered 25-Dec at 4:40pm

Mesoblast (NASDAQ:MESO) Shares Gap Up – Here’s Why

etfdailynews.com, discovered 25-Dec at 11:00am

Mesoblast scores first US nod for mesenchymal stromal cell therapy

bioworld.com, discovered 24-Dec at 11:00am

Mesoblast Director Increases Share Holdings Significantly

nasdaq.com, discovered 23-Dec at 10:49pm

US FDA approves Mesoblast’s mesenchymal stromal cell therapy, Ryoncil ...

pharmabiz.com, discovered 23-Dec at 9:30pm

Galloping to the top of the runners of the week podium is… icetana

smh.com.au, discovered 21-Dec at 6:04am

What’s Behind the 36.82% Gain in Mesoblast Ltd (MESO) Stock? Find Out ...

bovnews.com, discovered 20-Dec at 11:57pm

ASX tumbles to three-month low; ASX CHESS outage

afr.com, discovered 20-Dec at 4:48pm

MESO Stock Up as FDA Approves Ryoncil for Graft Versus Host Disease

au.finance.yahoo.com, discovered 20-Dec at 7:51am

Mesoblast wins long-await­ed ap­proval for cell ther­a­py

endpts.com, discovered 20-Dec at 7:17am

Mesoblast awarded FDA approval for Ryoncil

sharecafe.com.au, discovered 20-Dec at 7:13am

After two rejections, FDA approves Mesoblast's first-of-its-kind cell ...

fiercepharma.com, discovered 20-Dec at 2:24am

What's Going On With Mesoblast Shares Thursday?

benzinga.com, discovered 20-Dec at 1:22am

Mesoblast stock soars on FDA approval of Ryoncil

ph.investing.com, discovered 19-Dec at 11:28pm

Mesoblast has received FDA approval for its drug Ryoncil

goldcoastbulletin.com.au, discovered 19-Dec at 10:38pm

What’s Next for Mesoblast (MESO) After Their Big Nasdaq Announcement?

bovnews.com, discovered 19-Dec at 9:38pm

Mesoblast finally pushes GvHD cell therapy over finish line

pharmaphorum.com, discovered 19-Dec at 9:20pm

Mesoblast Finally Gets Its Approval In GVHD: Where Now?

seekingalpha.com, discovered 19-Dec at 8:28pm

US FDA approves Mesoblast's cell therapy for graft-versus-host disease

reuters.com, discovered 19-Dec at 7:47pm

ASX plummets to six-week low in broad sell-off

afr.com, discovered 19-Dec at 4:44pm

Mesoblast shares rocket on FDA approval, but CEO says risks remain

afr.com, discovered 19-Dec at 4:35pm

Closing Bell: All 11 sectors sell off, but Mesoblast jumps 52pc on FDA...

dailytelegraph.com.au, discovered 19-Dec at 3:58pm

Mesoblast’s RYONCIL® is the First U.S. FDA-Approved Mesenchymal Stroma...

biospace.com, discovered 19-Dec at 11:00am

Mesoblast's RYONCIL® is the First U.S. FDA-Approved Mesenchymal Stroma...

manilatimes.net, discovered 19-Dec at 11:00am

Health Check: Joy as Mesoblast wins its first FDA approval for a stem-...

stockhead.com.au, discovered 19-Dec at 11:00am

FDA approves Mesoblast’s Ryoncil for SR-aGvHD treatment

pharmaceutical-technology.com, discovered 19-Dec at 11:00am

Top-Notch Biotech Mesoblast Skyrockets On Immune Condition Approval

yahoo.com, discovered 19-Dec at 10:44am

Mesoblast ADRs Rise 22%, Company Joining Nasdaq Biotechnology Index

marketwatch.com, discovered 19-Dec at 10:20am

Dual-listed Mesoblast joins Nasdaq biotechnology index

capitalbrief.com, discovered 19-Dec at 1:17am

Mesoblast to be Added to Nasdaq Biotechnology Index

morningstar.com, discovered 18-Dec at 11:30pm

Mesoblast shares soar on FDA approval for Ryoncil therapy

capitalbrief.com, discovered 18-Dec at 11:00am

Mesoblast Limited American Depositary Shares (MESO) Short Interest

nasdaq.com, discovered 18-Dec at 4:11am

Mesoblast's Revascor gets FDA nod, but shares dip

finnewsnetwork.com.au, discovered 6-Dec at 2:32am

Mesoblast Secures Option for $50M Convertible Notes

miragenews.com, discovered 1-Oct at 2:00pm

The Overnight Report: Enough (For Now)

fnarena.com, discovered 1-Oct at 9:13am

Mesoblast: Undervalued Due To Remestemcel-L's Substantial Growth Poten...

seekingalpha.com, discovered 1-Oct at 6:24am

Dr Boreham’s Crucible: This stem cell and regenerative medicine firm h...

dailytelegraph.com.au, discovered 30-Sep at 6:30pm

ASX reaches another record high as energy rallies

capitalbrief.com, discovered 30-Sep at 4:32pm

Mesoblast Option To Issue Up To US$50 Million Convertible Notes For Pr...

menafn.com, discovered 30-Sep at 12:40pm

Mesoblast to raise $50m from top shareholder for product launch

capitalbrief.com, discovered 30-Sep at 11:41am

Micron Gains the Most in 13 Years After AI Boosts Forecast

au.finance.yahoo.com, discovered 27-Sep at 2:20am

A September Look At 52 Possible Buy And Hold Stocks: Micro/Small Caps

seekingalpha.com, discovered 25-Sep at 12:58am

Walmart upgraded, Starbucks downgraded: Wall Street's top analyst call...

finance.yahoo.com, discovered 24-Sep at 11:32pm

Dr. Roach: Med for Crohn’s disease needs to be changed due to melanoma

detroitnews.com, discovered 24-Sep at 2:00pm

Graft Versus Host Disease Market To Increase At A CAGR Of 9.9% During ...

menafn.com, discovered 22-Sep at 3:32pm

MESO Jan 2025 2.000 call

ca.finance.yahoo.com, discovered 21-Sep at 2:20pm

Register to track MSB and receive email alerts.